Zomedica Pharmaceuticals

Summary
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

History

Zomedica Pharmaceuticals Corp. was incorporated on April 12, 2018 under the laws of the State of Delaware and is a publicly traded company on the Toronto Venture Exchange under the symbol ZOM. The Company trades in the United States on the OTCQB under the symbol ZOMZF.


Mission
Zomedica’s mission is to give veterinarians the solutions that they need to practice their craft with confidence.

Vision
Zomedica strives to be the highest quality provider of products and services that enhance the lives of companion animals and their owners worldwide.

Key Team

Dr. Stephanie Laine Morley D.V.M., DVM (Consultant)

Mr. Anthony K. Blair (Chief Operating Officer)

Dr. William Carpenter MacArthur (Consultant)

Mr. Evan St. Peter (VP of Technology Innovation)

Ms. Karen DeHaan-Fullerton J.D. (Gen. Counsel, Chief Counsel & Corp. Sec.)

Ms. Nicole Westfall (VP of Marketing)

Ms. Kristin Domanski (VP of HR)


Recognition and Awards
Zomedica was ranked in the Deloitte Technology Fast50™ and was named EY Entrepreneur Of The Year in the Animal Health Category.

References
Zomedica Pharmaceuticals
Leadership team

Mr. Larry C. Heaton II (Pres & CEO)

Ms. Ann Marie Cotter CPA (Chief Financial Officer)

Mr. Adrian Lock (VP, GM & Head of Sales)

Products/ Services
Pharmaceutical, Veterinary
Headquarters
Ann Arbor, Michigan, United States
Established
2013
Company Registration
SEC CIK number: 0001684144
Revenue
5M - 20M
Traded as
ZOM
Social Media
Tue Apr 16 2024
About

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with
Logo

Copyright 2023 © businessabc powered by ztudium